medigraphic.com
Revista Latinoamericana de Microbiología

2004, Number 1-2

<< Back Next >>

Microbiología 2004; 46 (1-2)

Antibody response on mice immunized by mucosal routes with formalin inactivated enteropathogenic Escherichia coli (EPEC) strains

Drago-Serrano ME, Manjarréz HHA, Gavilanes PS, Sainz ETR

Language: Spanish
References: 29
Page: 17-23
PDF size: 72.74 Kb.


ABSTRACT

Secretory and systemic antibody response in mice against enteropathogenic Escherichia coli (EPEC) was evaluated. Groups of mice were immunized with formalin inactivated EPEC 0127:H6 strain by intranasal, peroral, intragastric and intrarectal route, with and without cholera toxin (CT) used as mucosal adjuvant. Mice immunized subcutaneously and a non treated control group were included. Other groups of mice were immunized intranasally with different EPEC strains and a non pathogenic E. coli K12 strain. Antibody response tested by ELISA assay showed that specific anti EPEC 0127:H6 antibodies were induced in serum by intranasal, subcutaneous and intragastric routes. A strong increase of antibody response against EPEC 0127:H6 strain was observed in saliva after intranasal delivery, while a lower response was detected by peroral and intrarectal immunization. Only the intranasal route increased IgA anti EPEC 0127:H6 antibody titers in feces. Specific and cross reactive antibodies to EPEC 0127:H6 were seen in mice immunized intranasally with different EPEC strains. Some control mice showed a background of anti EPEC 0127:H6 antibodies in feces. CT had a negative effect as adjuvant. We showed that nasal mucosa rendered the strongest antibody response in serum and secretions. These results might contribute to optimize the protective effect of enteric vaccines against infections associated to EPEC.


REFERENCES

  1. Berstad, A.K.H., J. Holst, B. Mögster, I.L. Haugen & B. Haneberg. 1997. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine. 15:1473-1478.

  2. 1a. Berg, R.D. & D.C. Savage. 1975. Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms. Infect. Immun. 11:320-329.

  3. Brandtzaeg, P. 2003. Role of secretory antibodies in defence against infections. Int. J. Med. Microbiol. 293:3-15.

  4. Brandwein, S.L., R.P. McCabe, Y. Cong, K.B. Waits, B.U. Ridwan, P.A. Dean, T. Ohkusa, E.H. Birkenmeier, J.P. Sundberg & Ch. Elson. 1997. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159:44-52.

  5. Byrd. W., S.R. Mog & F.J. Cassels. 2003. Pathogenicity and immune response measured in mice following intranasal challenge with Enterotoxigenic Escherichia coli strains H10407 and B7A. Infect. Immun. 71: 13-21.

  6. Clarke, S.C., R.D. Haigh, P.P. Freestone & P.H. Williams. 2002. Enteropathogenic Escherichia coli infection: history and clinical aspects. Br. J. Biomed. Sci. 59:123-127.

  7. Donnenberg, M.S., C.O. Tacket, G. Losonsky, G. Frankel, J.P. Nataro, G. Dougan & M.M. Levine. 1998. Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge. Infect. Immun. 66:52-58.

  8. "Deleted in proof" 67: 5917-5924.

  9. Haneberg, B., A.K.H. Berstad & J. Holst. 2001. Bacteria-derived particles as adjuvants for non-replicant nasal vaccines. Adv Drug Deliver Rev 51:143-147.

  10. Haneberg, B., D. Kendall, H.M. Amerongen, F.M. Apter, J.P. Kraehenbuhl & M.R. Neutra. 1994. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:15-23.

  11. Higgins, L.M., G. Frankel, I. Connerton, N.S. Gonçalves, G. Dougan & T.T. MacDonald. 1999. Role of bacterial intimin in colonic hyperplasia and inflammation. Science. 285:588-591.

  12. Hopkins, S., J.P. Krahenbuhl, F. Shödel, A. Potts, D. Peterson, P. De Grandi & D. Nardelli-Haefliger. 1995. A recombinant Salmonella thyphimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.

  13. Hordnes, K., T. Tynning, T.A. Brown, B. Haneberg & R. Jonsson. 1997. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice. Vaccine. 15:1244-1251.

  14. Horne, C., B.A. Vallance, W. Deng & B.B. Finlay. 2002. Current progress in enteropathogenic and enterohemorrhagic Escherichia coli vaccines. Expert. Rev. Vaccines. 1:483-493.

  15. Hvalbye, B.K.R., I. Aaberge, M. Løvik & B. Haneberg. 1999. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection. Infect. Immun. 67:4320-4325.

  16. Kozlowski, P.A., S. Cu-Uvin, M.R. Neutra & T.P. Flanigan. 1997. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65:1387-1394.

  17. Kraehenbuhl, J.P. & M. Neutra. 1992. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Revs. 72:853-879.

  18. Marcotte, H. & M.C. Lavoie. 1998. Oral microbiology and the role of salivary immunoglobulin A. Microbiol. Mol. Biol. Rev. 62:71-109.

  19. Martínez, M.B., C.R. Taddei, A. Ruiz-Tagle, L.R. Trabulsi & J.A. Girón. 1999. Antibody response of children with enteropathogenic Escherichia coli infection to bundle-forming pilus and locus of enterocyte effacement encoded virulence determinants. J. Infect. Dis. 179:269-274.

  20. Milon, A., J. Esslinger & R. Camguilhem. 1992. Oral vaccination of weaned rabbits against enteropathogenic Escherichia coli-like E. coli O103 infection: use of heterologous strains harboring lipopolysaccharide or adhesin of pathogenic strains. Infect. Immun. 60:2702-2709.

  21. Pace, J.L., H.A. Rossi, V.M. Esposito, S.M. Frey, K.D. Tucker & R.I. Walker. 1998. Inactivated whole-cell bacterial vaccines: current status and novel strategies. Vaccine. 16:1563-1574.

  22. Parissi-Crivelli, A., J.M. Parissi-Crivelli & J.A. Girón. 2000. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies. J. Clin. Microbiol. 38:2696-2700.

  23. Quintana-Flores, V.M., R.C. Campos de Souza Fernandes, Z. Sousa de Macedo & E. Medina-Acosta. 2002. Expression and purification of the recombinant enteropathogenic Escherichia coli vaccine candidates BfpA and EspB. Protein Expr Purif. 25:16-22.

  24. Roberts, J.A., M.B. Kaack, G. Baskin & S.B. Svenson. 1995. Vaccination with a formalin-killed P-fimbriated E. coli whole cell vaccine prevents renal scarring from pyelonephritis in the non-human primate. Vaccine. 13:11-16.

  25. Robins-Browne, R.M., A.M. Tokhi, L.M. Adams & V. Bennett-Wood. 1994. Host specificity of enteropathogenic Escherichia coli from rabbits: lack of correlation between adherence in vitro and pathogenicity for laboratory animals. Infect. Immun. 62:3329-3336.

  26. 24a. Schriefer, A., J. R. Maltez., N. Silva., M. Y. Stoeckle., M. Barral-Netto & L.W. Riley. 1999. Expression of a pilin subunit BfpA of the bundle forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain. Vaccine. 17:770-778.

  27. Vallance, B.A., C. Chan, M.L. Robertson & B.B. Finlay. 2002. Enteropathogenic and enterohemorrhagic Escherichia coli infections: emerging themes in pathogenesis and prevention. Can. J. Gastroenterol. 16:771-778.

  28. Von Moll, L.K. & J.R. Cantey. 1997. Peyer´s patch adherence of enteropathogenic Escherichia coli strains in rabbits. Infect. Immun. 65:3788-3793.

  29. Wu, H-Y., H.H. Nguyen & M.W. Russell. 1997. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand. J. Immunol. 46:506-513.




2020     |     www.medigraphic.com